Diaphorina citri psyllid: psy16825

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180---
DGIKEEELPRRLCLVCGDVASGFHYGVASCEACKAFFKRTIQGNIEYTCPASNDCEINKRRRKACQACRFQKCLRKGMLKEGVRLDRVRGGRQKYRRNPDLLSQQWPPNKSIPSLEDLERNTEISCTQVIDRLEHVAVSKEEYYFLKALVLANSDVKLDEFSSLKKFRNSILSSLGDCIYVLR
ccccccccccccccccccccccccccccccccccHHHHHHcccccCECccccccccccccccccccHHHHHHHHHHccccHHccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHcc
*********RRLCLVCGDVASGFHYGVASCEACKAFFKRTIQGNIEYTCPASNDCEINKRRRKACQACRFQKCLRKGML******************************************TEISCTQVIDRLEHVAVSKEEYYFLKALVLANSDVKLDEFSSLKKFRNSILSSLGDCIYVLR
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
DGIKEEELPRRLCLVCGDVASGFHYGVASCEACKAFFKRTIQGNIEYTCPASNDCEINKRRRKACQACRFQKCLRKGMLKEGVRLDRVRGGRQKYRRNPDLLSQQWPPNKSIPSLEDLERNTEISCTQVIDRLEHVAVSKEEYYFLKALVLANSDVKLDEFSSLKKFRNSILSSLGDCIYVLR

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Steroid hormone receptor ERR1 Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism.confidentP11474
Steroid hormone receptor ERR1 Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism.confidentQ5QJV7
Steroid hormone receptor ERR1 Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism.confidentO08580

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0001077 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcriptionprobableGO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0035075 [BP]response to ecdysoneprobableGO:1901700, GO:0033993, GO:0050896, GO:1901654, GO:0008150, GO:0042221, GO:0036314, GO:0097305, GO:0010033, GO:0014070
GO:0060011 [BP]Sertoli cell proliferationprobableGO:0048610, GO:0061458, GO:0008584, GO:0007275, GO:0044699, GO:0000003, GO:0046546, GO:0008406, GO:0045137, GO:0048513, GO:0032502, GO:0032501, GO:0048608, GO:0008283, GO:0009987, GO:0044767, GO:0003006, GO:0008150, GO:0046661, GO:0007548, GO:0044707, GO:0022414, GO:0048856, GO:0050673, GO:0048731
GO:0044429 [CC]mitochondrial partprobableGO:0005737, GO:0005575, GO:0043231, GO:0044464, GO:0043229, GO:0005739, GO:0005622, GO:0044446, GO:0044444, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0060065 [BP]uterus developmentprobableGO:0032502, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0022414, GO:0061458, GO:0048856, GO:0044767, GO:0003006, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0060068 [BP]vagina developmentprobableGO:0032502, GO:0007548, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0022414, GO:0061458, GO:0048856, GO:0030540, GO:0045137, GO:0044767, GO:0003006, GO:0048513, GO:0048806, GO:0008150, GO:0048731, GO:0046545, GO:0046660, GO:0007275, GO:0044699
GO:0044323 [MF]retinoic acid-responsive element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0005652 [CC]nuclear laminaprobableGO:0034399, GO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0043204 [CC]perikaryonprobableGO:0044464, GO:0044297, GO:0005623, GO:0005575, GO:0097458, GO:0043025
GO:0051091 [BP]positive regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:0044093, GO:2001141, GO:0008150, GO:0065009, GO:0010468
GO:0000978 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA bindingprobableGO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001159, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0000987, GO:0003674, GO:0097159, GO:1901363, GO:0005488
GO:0009410 [BP]response to xenobiotic stimulusprobableGO:0042221, GO:0050896, GO:0008150
GO:0048384 [BP]retinoic acid receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0048386 [BP]positive regulation of retinoic acid receptor signaling pathwayprobableGO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0048385, GO:0050789, GO:0048522
GO:0045177 [CC]apical part of cellprobableGO:0005575, GO:0044464, GO:0005623
GO:1901215 [BP]negative regulation of neuron deathprobableGO:0060548, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:1901214, GO:0010941, GO:0050789, GO:0048523
GO:0045070 [BP]positive regulation of viral genome replicationprobableGO:0050792, GO:0045069, GO:2000241, GO:0050794, GO:0043902, GO:0043900, GO:0065007, GO:0008150, GO:2000243, GO:0048518, GO:0048524, GO:0050789, GO:0048522
GO:0045742 [BP]positive regulation of epidermal growth factor receptor signaling pathwayprobableGO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0042058, GO:0023056, GO:0048518, GO:0050789, GO:0065007, GO:0023051, GO:1901186, GO:0008150, GO:1901184, GO:0010646, GO:0010647, GO:0050794, GO:0048522
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0035239 [BP]tube morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0008150, GO:0035295, GO:0009653, GO:0007275, GO:0044699
GO:0030315 [CC]T-tubuleprobableGO:0042383, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0050877 [BP]neurological system processprobableGO:0032501, GO:0008150, GO:0044699, GO:0044707, GO:0003008
GO:2000020 [BP]positive regulation of male gonad developmentprobableGO:2000018, GO:0051094, GO:0050793, GO:2000243, GO:2000241, GO:0008150, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0019048 [BP]virus-host interactionprobableGO:0044419, GO:0044703, GO:0000003, GO:0009987, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0016032, GO:0044403, GO:0051701, GO:0051704
GO:0001831 [BP]trophectodermal cellular morphogenesisprobableGO:0032502, GO:0030154, GO:0048468, GO:0009790, GO:0009792, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0001829, GO:0048869, GO:0001825, GO:0001824, GO:0016043, GO:0032989, GO:0071840, GO:0043009, GO:0048646, GO:0048598, GO:0032501, GO:0009987, GO:0044767, GO:0001701, GO:0044763, GO:0044707, GO:0048856, GO:0008150
GO:0001834 [BP]trophectodermal cell proliferationprobableGO:0032502, GO:0032501, GO:0044707, GO:0001701, GO:0040007, GO:0048589, GO:0008283, GO:0001832, GO:0001824, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699, GO:0048856
GO:0048521 [BP]negative regulation of behaviorprobableGO:0048585, GO:0048583, GO:0050795, GO:0008150, GO:0065007, GO:0048519, GO:0050789
GO:0043523 [BP]regulation of neuron apoptotic processprobableGO:0050794, GO:0043067, GO:0065007, GO:0008150, GO:1901214, GO:0010941, GO:0042981, GO:0050789
GO:0042445 [BP]hormone metabolic processprobableGO:0065007, GO:0065008, GO:0008150, GO:0008152, GO:0010817
GO:0045667 [BP]regulation of osteoblast differentiationprobableGO:0050793, GO:0050794, GO:0045595, GO:0065007, GO:0051239, GO:0008150, GO:0030278, GO:0050789
GO:0002064 [BP]epithelial cell developmentprobableGO:0032502, GO:0060429, GO:0048869, GO:0030154, GO:0048468, GO:0009888, GO:0044767, GO:0044763, GO:0030855, GO:0008150, GO:0009987, GO:0044699, GO:0048856
GO:0006935 [BP]chemotaxisprobableGO:0040011, GO:0042330, GO:0009605, GO:0050896, GO:0008150, GO:0042221
GO:0046966 [MF]thyroid hormone receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0000790 [CC]nuclear chromatinprobableGO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0019827 [BP]stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0051000 [BP]positive regulation of nitric-oxide synthase activityprobableGO:0050999, GO:0032770, GO:0051341, GO:0019222, GO:0032768, GO:0050790, GO:0051353, GO:0065007, GO:0044093, GO:0008150, GO:0065009, GO:0050789, GO:0043085
GO:0003690 [MF]double-stranded DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0043401 [BP]steroid hormone mediated signaling pathwayprobableGO:0071383, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0050789, GO:0044699, GO:0009755, GO:0051716, GO:0033993, GO:0071310, GO:0065007, GO:0014070, GO:0071495, GO:0009719, GO:0009987, GO:0071396, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0048545
GO:0030900 [BP]forebrain developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0006367 [BP]transcription initiation from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0006352, GO:0019438
GO:0043154 [BP]negative regulation of cysteine-type endopeptidase activity involved in apoptotic processprobableGO:0019222, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0044699, GO:0051346, GO:2000116, GO:2000117, GO:0043086, GO:0043067, GO:0010466, GO:0065007, GO:0044092, GO:0043281, GO:0065009, GO:0010259, GO:0006915, GO:0052547, GO:0052548, GO:0009987, GO:0050794, GO:0012501, GO:0044763, GO:0010951, GO:0051336, GO:0050790, GO:0008150
GO:0071300 [BP]cellular response to retinoic acidprobableGO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0019899 [MF]enzyme bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0045670 [BP]regulation of osteoclast differentiationprobableGO:0002761, GO:0050793, GO:0045595, GO:0050794, GO:0050789, GO:1902105, GO:0065007, GO:2000026, GO:0008150, GO:0051239, GO:0002682, GO:0045637
GO:0032403 [MF]protein complex bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0070374 [BP]positive regulation of ERK1 and ERK2 cascadeprobableGO:0023056, GO:0048584, GO:0010646, GO:0009966, GO:0009967, GO:0010740, GO:0048583, GO:0050794, GO:0043410, GO:0050789, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0048522, GO:0010627, GO:0070372, GO:0043408
GO:0014706 [BP]striated muscle tissue developmentprobableGO:0032502, GO:0048856, GO:0008150, GO:0009888, GO:0060537
GO:0001046 [MF]core promoter sequence-specific DNA bindingprobableGO:0044212, GO:0003676, GO:0043565, GO:0097159, GO:0000975, GO:0001067, GO:0000976, GO:0005488, GO:0001047, GO:0003677, GO:0003674, GO:1901363
GO:0005975 [BP]carbohydrate metabolic processprobableGO:0044238, GO:0008150, GO:0008152, GO:0071704
GO:0003705 [MF]RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0042974 [MF]retinoic acid receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0008202 [BP]steroid metabolic processprobableGO:0044238, GO:0044710, GO:0006629, GO:0071704, GO:0008150, GO:0008152, GO:1901360
GO:0043124 [BP]negative regulation of I-kappaB kinase/NF-kappaB cascadeprobableGO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0050789, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048523, GO:0010646, GO:0010627, GO:0010741, GO:0043122
GO:0043433 [BP]negative regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0019904 [MF]protein domain specific bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0051216 [BP]cartilage developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0061448, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0030375 [MF]thyroid hormone receptor coactivator activityprobableGO:0030545, GO:0030546, GO:0003713, GO:0003712, GO:0030374, GO:0003674, GO:0000989, GO:0000988, GO:0010861
GO:0008013 [MF]beta-catenin bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0005543 [MF]phospholipid bindingprobableGO:0043168, GO:0043167, GO:0003674, GO:0008289, GO:0005488
GO:0045429 [BP]positive regulation of nitric oxide biosynthetic processprobableGO:0009889, GO:0009893, GO:0019222, GO:0009891, GO:0031326, GO:0031325, GO:0031328, GO:0031323, GO:0050794, GO:0045428, GO:0065007, GO:0051171, GO:0051173, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0051321 [BP]meiotic cell cycleprobableGO:0048610, GO:0000003, GO:0009987, GO:0044763, GO:0007049, GO:0008150, GO:0044699
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0042809 [MF]vitamin D receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0060740 [BP]prostate gland epithelium morphogenesisprobableGO:0061458, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0000003, GO:0030850, GO:0048513, GO:0048729, GO:0022612, GO:0032502, GO:0009887, GO:0032501, GO:0048608, GO:0060429, GO:0009888, GO:0044767, GO:0003006, GO:0008150, GO:0001655, GO:0044707, GO:0022414, GO:0048856, GO:0048731, GO:0048732, GO:0060512
GO:0051146 [BP]striated muscle cell differentiationprobableGO:0032502, GO:0048856, GO:0048869, GO:0030154, GO:0044767, GO:0044763, GO:0061061, GO:0008150, GO:0009987, GO:0042692, GO:0044699
GO:0008232 [CC]activator ecdysone receptor complexprobableGO:0031974, GO:0043229, GO:0008230, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0043235, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0005667, GO:0044424, GO:0044422
GO:0060135 [BP]maternal process involved in female pregnancyprobableGO:0044703, GO:0044702, GO:0048609, GO:0032504, GO:0044706, GO:0007565, GO:0022414, GO:0032501, GO:0008150, GO:0051704, GO:0044699, GO:0000003
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0051726 [BP]regulation of cell cycleprobableGO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0004886 [MF]9-cis retinoic acid receptor activityprobableGO:0003708, GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0007517 [BP]muscle organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0061061, GO:0048731, GO:0007275, GO:0044699
GO:0071392 [BP]cellular response to estradiol stimulusprobableGO:0071383, GO:0070887, GO:0014070, GO:0009719, GO:0032355, GO:0033993, GO:0071310, GO:0044699, GO:0071495, GO:0009987, GO:0071391, GO:0071396, GO:0051716, GO:0032870, GO:0044763, GO:0043627, GO:0042221, GO:0010033, GO:1901700, GO:1901701, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0097305, GO:0048545, GO:0097306
GO:0070644 [MF]vitamin D response element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0030518 [BP]intracellular steroid hormone receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0005496 [MF]steroid bindingprobableGO:0097159, GO:0003674, GO:0008289, GO:0005488
GO:0043195 [CC]terminal boutonprobableGO:0044306, GO:0043679, GO:0044463, GO:0044464, GO:0005623, GO:0030424, GO:0005575, GO:0097458, GO:0044456, GO:0045202, GO:0043005, GO:0033267, GO:0042995
GO:0051457 [BP]maintenance of protein location in nucleusprobableGO:0034504, GO:0033036, GO:0008104, GO:0032507, GO:0070727, GO:0072595, GO:0034613, GO:0065007, GO:0045185, GO:0009987, GO:0044763, GO:0033365, GO:0008150, GO:0051235, GO:0065008, GO:0051651, GO:0051179, GO:0044699, GO:0051641
GO:0002042 [BP]cell migration involved in sprouting angiogenesisprobableGO:0006928, GO:0072359, GO:0072358, GO:0001667, GO:0009653, GO:0007275, GO:0044699, GO:0043542, GO:0001525, GO:0001568, GO:0001944, GO:0051179, GO:0048514, GO:0016477, GO:0002040, GO:0048646, GO:0032502, GO:0032501, GO:0009987, GO:0044767, GO:0043534, GO:0008150, GO:0090132, GO:0090130, GO:0040011, GO:0010631, GO:0044707, GO:0048870, GO:0048856, GO:0044763, GO:0051674, GO:0048731
GO:0000980 [MF]RNA polymerase II distal enhancer sequence-specific DNA bindingprobableGO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0034056 [MF]estrogen response element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0031641 [BP]regulation of myelinationprobableGO:0051239, GO:0044057, GO:0031644, GO:0032844, GO:0008150, GO:0050793, GO:2000021, GO:2000026, GO:0051960, GO:0023051, GO:0065007, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0042562 [MF]hormone bindingprobableGO:0003674, GO:0005488
GO:0001662 [BP]behavioral fear responseprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0007610, GO:0006952, GO:0006950, GO:0002209, GO:0042596, GO:0033555, GO:0008150, GO:0044699
GO:0001541 [BP]ovarian follicle developmentprobableGO:0022602, GO:0061458, GO:0008585, GO:0048608, GO:0007275, GO:0044699, GO:0000003, GO:0008406, GO:0045137, GO:0048511, GO:0048513, GO:0032502, GO:0032501, GO:0046545, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0046660, GO:0007548, GO:0044702, GO:0044707, GO:0003006, GO:0048856, GO:0042698, GO:0048731
GO:0001892 [BP]embryonic placenta developmentprobableGO:0032502, GO:0001701, GO:0044707, GO:0048568, GO:0032501, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0044699, GO:0009792, GO:0048731, GO:0043009, GO:0007275, GO:0001890
GO:0002165 [BP]instar larval or pupal developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0009791, GO:0008150, GO:0007275, GO:0044699
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0035357 [BP]peroxisome proliferator activated receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0048666 [BP]neuron developmentprobableGO:0032502, GO:0048699, GO:0048856, GO:0007399, GO:0030182, GO:0009987, GO:0048869, GO:0030154, GO:0048468, GO:0044767, GO:0032501, GO:0044763, GO:0048731, GO:0008150, GO:0022008, GO:0007275, GO:0044699, GO:0044707
GO:0038052 [MF]estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activityprobableGO:0038023, GO:0004879, GO:0003700, GO:0003707, GO:0060089, GO:0003674, GO:0004872, GO:0004871, GO:0030284, GO:0000981, GO:0001071
GO:0008270 [MF]zinc ion bindingprobableGO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3DZY, chain A
Confidence level:very confident
Coverage over the Query: 10-182
View the alignment between query and template
View the model in PyMOL